{
    "Trade/Device Name(s)": [
        "HCT Extended Hematology Control"
    ],
    "Submitter Information": "R&D Systems, Inc.",
    "510(k) Number": "K073178",
    "Predicate Device Reference 510(k) Number(s)": [
        "K843962"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JPK"
    ],
    "Summary Letter Date": "December 27, 2007",
    "Summary Letter Received Date": "November 13, 2007",
    "Submission Date": "November 12, 2007",
    "Regulation Number(s)": [
        "21 CFR 864.8625"
    ],
    "Regulation Name(s)": [
        "Hematology Quality Control Mixture"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "Hematocrit"
    ],
    "Specimen Type(s)": [
        "Whole blood (control material)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for HCT Extended Hematology Control, a whole blood assayed control to monitor hematocrit values on automated and manual methods.",
    "Indications for Use Summary": "An assayed control designed to monitor values obtained from automated, semi-automated, and manual methods for in vitro diagnostic use.",
    "fda_folder": "Hematology"
}